SR | Efficacy of CAR-T cell therapy vs. auto-HSCT in relapsed or refractory diffuse large B-cell lymphoma SPECIALTIES, 06 Feb 2023 Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse…